Stock Price Quote

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE3769.40-40.3 (-1.06 %)
PREV CLOSE ( ) 3809.70
OPEN PRICE ( ) 3755.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4121
TODAY'S LOW / HIGH ( )3752.00 3820.00
52 WK LOW / HIGH ( )3000 4970
NSE3773.05-35.35 (-0.93 %)
PREV CLOSE( ) 3808.40
OPEN PRICE ( ) 3780.00
BID PRICE (QTY) 3773.05 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18371
TODAY'S LOW / HIGH( ) 3763.15 3822.05
52 WK LOW / HIGH ( )3005 4970
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1979
Management Info
Narayan K Seshadri - Chairman Gagandeep Singh Bedi - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX

NEWS

01Jun Termination Of Distribution Agreement
We refer to our announcement of December 7, 2018, wherein we had informe..
28May AstraZeneca Pharma, Abbott Healthcare
AstraZeneca Pharma and Abbott Healthcare have mutually terminated the di..
26May Reappointment Of Statutory Auditors F
The Board of Directors of the Company at their meeting held on May 25, 2..
19May Board Meeting Intimation for Meeting
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Bo..
19May Astrazeneca Pharma India informs about
Astrazeneca Pharma India has informed that a meeting of the Board of Dir..

Financials

in Millions
QTR Mar 21 ANNUAL 21
Net Profit272.78933.039999999999
Gross Profit 368.38 1270.94
Operating Profit 429.621483.13
Net Sales 2102.578135.63

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2083.85 (1.39%)
M.Cap ( in Cr)1287.41
Natco Pharma (BSE)
peergroup  1131.25 (2.25%)
M.Cap ( in Cr)20626.97
Orchid Pharma (BSE)
peergroup  1371.50 (1.75%)
M.Cap ( in Cr)5597.97
JB Chem & Pharma (BSE)
peergroup  1526.30 (1.34%)
M.Cap ( in Cr)11795.57
SMS Lifesciences (BSE)
peergroup  646.55 (1.74%)
M.Cap ( in Cr)195.47

Shareholding Pattern

PROMOTERS 75%
NON-INSTITUTION 21.64%
MUTUAL FUNDS/UTI 0.83%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Astrazeneca Pharma India Ltd.

Astrazeneca Pharma India Ltd. was incorporated in the year 1979. Its today's share price is 3769.4. Its current market capitalisation stands at Rs 9423.5 Cr. In the latest quarter, company has reported Gross Sales of Rs. 8318.1 Cr and Total Income of Rs.8448 Cr. The company's management includes Ankush Nandra, Pratap Rudra, Rajesh Marwaha, Gagandeep Singh Bedi, Weiying Sarah Wang, Kimsuka Narsimhan, Revathy Ashok, Narayan K Seshadri.

It is listed on the BSE with a BSE Code of 506820 , NSE with an NSE Symbol of ASTRAZEN and ISIN of INE203A01020. It's Registered office is at Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring RoadBengaluru-560045, Karnataka. Their Registrars are ACC Ltd. It's auditors are AF Ferguson & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, Price Waterhouse & Co, Price Waterhouse & Co Chartered Accountants LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)